Tejnaksh Healthcare Faces Evaluation Adjustment Amidst Declining Performance Metrics
Tejnaksh Healthcare, a microcap in the healthcare sector, has recently adjusted its evaluation score due to changes in stock performance metrics. The company reported flat financial results for the quarter ending March 2025, with declining net sales over five years and consistent underperformance against benchmark indices.
Tejnaksh Healthcare, a microcap company in the healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical trends observed in the stock's performance metrics. The company has reported a flat financial performance for the quarter ending March 2025, with key indicators such as PBDIT and PBT reaching their lowest levels. Over the past five years, Tejnaksh Healthcare has experienced a decline in net sales, with a compound annual growth rate (CAGR) of -5.12%. Despite this, the company has maintained an average return on equity (ROE) of 9.96%, indicating a modest level of profitability relative to shareholders' funds.
In terms of market performance, Tejnaksh Healthcare has consistently underperformed against the benchmark indices over the last three years, with a return of -13.46% in the past year. The stock is currently trading at a price-to-book value of 1.6, which is considered attractive compared to its peers.
Overall, the recent evaluation adjustment highlights the ongoing challenges faced by Tejnaksh Healthcare amidst a backdrop of fluctuating technical indicators and long-term performance metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
